MAPK8 and leukemia: Our results highlight that CD274/JNK/Cyclin D2 signaling controls the cell cycle entry of LICs and leukemia development, which may be helpful for the further identification and understanding of the role of other novel surface immune molecules in the maintenance of LIC pool.